NEPTUNE WELLNESS SOLUTIONS INC.

Profile

Company Names

NEPTUNE WELLNESS SOLUTIONS INC.
NEPTUNE TECHNOLOGIES + BIORESSOURCES INC.

Addresses

100-545 PROMENADE DU CENTROPOLIS, LAVAL, A8 H7T 0A3

545 PROMENADE DU CENTROPOLIS, SUITE 100, LAVAL, A8 H7T 0A3

225 PROMENADE DU CENTROPOLIS, SUITE 200, LAVAL, A8 H7T 0B3

Phone Numbers

(450) 687-2262
(888) 664-9166

 

Entity Type:

CORPORATION

Industry:

OTHER, PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

QUEBEC, CANADA

Total Amount Raised:

$93,734,992.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-07-13 
$3,599,999.00 
$3,599,999.00 
$0.00 
Equity 
4
2021-02-10 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
3
2020-10-21 
$34,999,992.00 
$58,697,894.00 
$23,697,902.00 
Equity 
2
2019-07-17 
$37,010,001.00 
$37,010,001.00 
$0.00 
Equity 
1
2011-05-02 
$6,125,000.00 
$6,125,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JESSICA 
 
ADKINS 
EXECUTIVE OFFICER
MORRY 
 
BROWN 
EXECUTIVE OFFICER
JOSEPH 
 
BUARON 
DIRECTOR
MICHAEL 
 
CAMMARATA 
EXECUTIVE OFFICER, DIRECTOR
MICHEL 
 
CHARTRAND 
DIRECTOR
KATHERINE 
 
CREWE 
DIRECTOR
MICHAEL 
 
DE GEUS 
DIRECTOR
MICHAEL 
A. 
DE GEUS 
DIRECTOR
JEAN-CLAUDE 
 
DEBARD 
DIRECTOR
EMILY 
 
FLETTY 
EXECUTIVE OFFICER
HELENE 
F. 
FORTIN 
DIRECTOR
HENRI 
 
HARLAND 
DIRECTOR, EXECUTIVE OFFICER
JOHN 
 
MORETZ 
DIRECTOR
MARIO 
 
PARADIS 
EXECUTIVE OFFICER
JANE 
 
PEMBERTON 
DIRECTOR
DANIEL 
 
PERRY 
DIRECTOR
JULIE 
 
PHILLIPS 
DIRECTOR
TONI 
 
RINOW 
EXECUTIVE OFFICER
FRANCIS 
F. 
ROCHON 
DIRECTOR
TINA 
 
SAMPALIS 
EXECUTIVE OFFICER
PHILIP 
 
SANFORD 
DIRECTOR
RICHARD 
F. 
SCHOTTENFELD 
DIRECTOR
RICK 
 
SCHOTTENFELD 
DIRECTOR
RAYMOND 
 
SILCOCK 
EXECUTIVE OFFICER
JOHN 
 
WIRT 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-13 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-02-10 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-10-21 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-07-17 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-05-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
NONE
NONE
COWEN AND COMPANY, LLC
NONE
NONE
ROTH CAPITAL PARTNERS